Hypercalcemia - PowerPoint PPT Presentation

1 / 34
About This Presentation
Title:

Hypercalcemia

Description:

61 yrs old WM who has not seen his PCP for the past 10 yrs. C/O weakness for 2 m with loss of weight 20 lbs. ... Heavy alcohol drinker in the past. Social Hx ... – PowerPoint PPT presentation

Number of Views:106
Avg rating:3.0/5.0
Slides: 35
Provided by: victorg4
Category:

less

Transcript and Presenter's Notes

Title: Hypercalcemia


1
Morning Report 4/5/2000
Victor Ghobrial, MD
Thomas McGlynn, MD
2
HPI
  • 61 yrs old WM who has not seen his PCP for the
    past 10 yrs.
  • C/O weakness for 2 m with loss of weight 20 lbs..
  • He retired from his job as a plumber 3 m back and
    was doing a private job when he felt too weak to
    perform and only then he realized he was
    deteriorating.

3
Past Med Hx
  • Pneumonia 10 years ago
  • No CAD
  • No HTN
  • No DM
  • NO CA

4
Meds
  • ASA
  • Tums lots of
  • NKDA

5
Social Hx
  • Retired Plumber who worke din heating systems an
    din cleaning out soot.
  • Heavy smoker 1 p/day for gt 30 yrs
  • Heavy alcohol drinker in the past

6
ROS
  • Loss of weight 20lbs over 2 m in spite of good
    appetite.
  • No fever, night sweats cough or SOB.
  • No dysuria or frequency.
  • No abdominal pain, diarrhea or constipation.
  • No skin rash or other symptoms.

7
Physical Exam
  • 61 male asthenic physique
  • Vitals WNL
  • HEENT unremarkable
  • Neck supple, no JVD or carotid bruits
  • Ht RRR S1 S2 audible
  • Lungs CTAs B/L
  • Abd Soft, no organomegally
  • Ext No E,C,C ve PP
  • Neuro Awake and alert but disoriented X3. No
    neuro deficits

8
Labs
  • Hgb Hct WBCs Plat

    11.0 32 6.5
    243
  • Cr BUN Na K Cl CO2
    3.2
    33 134 3.1 94 30
  • Ca 15.8 Phos 2.6
  • CK CKMB CKI TroponinI
    493 9.1
    1.8 0.4

9
What do you think?
  • Confused
  • Lost 20 lbs over 2 m
  • Hypercalcemic
  • Renal insufficiency
  • Physical exam WNL

10
Hypercalcemia
Hyperparathyroidism
Malignancy
Metabolic Dis.
11
Hyperparathyroidism
  • It is the most common cause in ambulatory
    patients, accounting for gt90 percent of cases.
  • Parathyroid hormone causes
    - increased bone resorption
    - GI
    absorption
    - renal absorption

12
(No Transcript)
13
Our patient.
  • PTH 5.9
  • Calcium 13.2
  • Makes you think..?

14
Malignancy
  • Among hospitalized patients, cancer is the most
    common cause, accounting for about 65 percent of
    cases, and hyperparathyroidism accounts for
    another 25 percent.
  • Increased bone resorbtion osteoclast activity
  • PTH-related substance secreted by tumors
  • Direct erosion by tumor cells

15
Hypercalcemia in Malignancy
Common in these neoplasms
  • Solid tumor
  • breast
  • lung
  • pancreas
  • kidneys
  • ovary
  • Hematolgic
  • myeloma
  • lymphosarcoma

16
Multiple Myeloma
  • Serum protein electrophoresis -ve
  • Urine protein electrophoresis -ve
  • Bone Marrow Bx -ve

17
Hypercalcemia Rx
  • IVFNSS Lasix ( renal secretion)
  • Pamidronate ( osteoclast activity)
  • Calcitonin ( bone calcification)

18
Hospital Course.....
  • Pt responded to therapy.
  • Hypercalcimia resolved.
  • Renal failure improved.
  • Pt regained baseline mental functioning.

19
Now what next ?...
  • Work up for an occult malignancy
  • Lung CT of chest was -ve
  • GI CEA 2.0, Colonoscopy -ve,
    EGD peptic ulcer Rx
    PPI
  • Blood work up for MM -ve
  • Prostate PSA 18.3

20
ANY CHANGE IN YOUR THOUGHTS?
21
Prostate Bx
  • Moderate to poorly differentiated adenocarcinoma
    of prostate, Gleason 8.
  • Prostate carcinoma involves 70 of the prostate
    tissue.

22
Prostate Cancer
23
Carcinoma of the prostate
  • Detected either clinically or at autopsy as a
    microscopic, pathologically well-differentiated
    tumor of little clinical importance.
  • Estimates are that 179,300 men will be diagnosed
    with prostate cancer in 1999 and that 37,000
    deaths will occur.
  • Prostate cancer is the most common cancer in men
    in the United States except for non-melanoma skin
    cancer.

24
Increase in incidence
  • The reasons are not known.
  • The incidence of microscopic cancer is similar in
    Japanese and white men in the United States, but
    the incidence of clinically evident disease is
    much higher in American men.
  • Japanese men who migrate to the mainland United
    States develop prostate cancer at a similar rate
    as white men.
  • Findings suggest that both genetic and
    environmental factors are operative in the
    conversion of microscopic into evident prostate
    cancer.

25
CLINICAL PRESENTATION
  • The manner in which the disease is diagnosed
    today is different from that of 10 years ago.
  • In the past prostate cancer was first detected by
    digital rectal examination or because the patient
    had urinary symptoms.
  • In the 1990s, prostate cancer is often diagnosed
    after a man has been found to have an elevated
    screening serum PSA concentration.

26
Symptomatic presentation
  • Symptoms are usually related to urinary tract
    obstruction caused by prostatic enlargement
    (urgency, nocturia, frequency, and hesitancy)
  • Because benign prostatic hyperplasia is so
    common, prostate cancer may exist in men who also
    have benign prostatic hyperplasia (BPH).

27
Asymptomatic presentation
  • Prostate cancer that is asymptomatic can be
    detected as a firm nodule on a routine digital
    rectal examination or, with increasing frequency,
    by an elevated serum PSA concentration.

28
PSA concentration
  • Malignant tissue generates more PSA than normal
    or hyperplastic tissue.
  • Cancerous tissue may disrupt the prostate-blood
    barrier, further increasing the serum
    concentration of PSA.
  • A serum PSA concentration gt4.0 ng/mL is
    considered abnormal in most assays.

29
PSA concentration
  • A serum PSA of 4.1 to 10.0 ng/mL increases the
    likelihood of finding intracapsular and
    extracapsular tumors by 1.4 to 3.0 and 3.2 to
    5.1-fold, respectively.
  • A serum PSA greater than 10.0 ng/mL increases the
    likelihood of finding intracapsular and
    extracapsular tumors by 0.4 to 3.0 and 23 to
    50-fold, respectively.

30
Prostatic biopsy
  • Mandatory if the serum PSA concentration is
    greater than 10 ng/mL, even in the presence of a
    normal rectal examination and ultrasonography.
  • Increasing numbers of men are undergoing biopsy
    for any elevation of serum PSA.

31
DIAGNOSTIC STUDIES
  • The positive predictive value of digital rectal
    examination for identifying prostate cancer
    varies from 15 to 30 percent .
  • The positive predictive value of serum PSA
    testing is similarly low, ranging from 17 to 28
    percent .
  • Transrectal ultrasonography also has a relatively
    low positive predictive value. The primary use of
    this procedure is to guide prostate biopsy.

32
Prostate Biopsy
  • The gold standard for prostate cancer diagnosis.
  • Obtain a specimen with a biopsy gun in any
    suspicious areas.
  • Complications include only mild rectal spotting,
    hematospermia, or hematuria rarely, patients
    experience more significant rectal bleeding or
    sepsis.

33
Tumor Histology (Gleason scale)
  • Tumors are graded from one to five based upon the
    degree of glandular differentiation and
    structural architecture.
  • Grade one represents the most well-differentiated
    appearance and grade five represents the most
    poorly differentiated.
  • A primary score and a secondary score is then
    given.
  • The prognosis is directly related to the pattern
    score.

34
Thank You
Write a Comment
User Comments (0)
About PowerShow.com